Patent ID: 6350740
Filing Date: 2002-02-26
Classification: A61K,C07F

Abstract:
A method for treating tumors in patients, comprising the step of administering to a patient in need thereof an effective amount of a platinum coordination compound wherein said platinum coordination compound is a salt, the cationic component of which is:â€ƒSP-4-2-[PtX(L)(Lâ€²)(B)]+wherein,X is an anionic ligand; L and Lâ€² are selected from the group consisting of NH3 and heterocyclic amines where the substituents are electrophilic or nucleophilic, and L and Lâ€² may be the same or different, and B is a sulfoxide or a nitrogen-containing nucleobase with a nitrogen in a ring which is connected to Pt.